4.6 Article

Genomic Interaction Profiles in Breast Cancer Reveal Altered Chromatin Architecture

期刊

PLOS ONE
卷 8, 期 9, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0073974

关键词

-

资金

  1. DOD [BC102122]
  2. Research Service of the Department of Veterans Affairs

向作者/读者索取更多资源

Gene transcription can be regulated by remote enhancer regions through chromosome looping either in cis or in trans. Cancer cells are characterized by wholesale changes in long-range gene interactions, but the role that these long-range interactions play in cancer progression and metastasis is not well understood. In this study, we used IGFBP3, a gene involved in breast cancer pathogenesis, as bait in a 4C-seq experiment comparing normal breast cells (HMEC) with two breast cancer cell lines (MCF7, an ER positive cell line, and MDA-MB-231, a triple negative cell line). The IGFBP3 long-range interaction profile was substantially altered in breast cancer. Many interactions seen in normal breast cells are lost and novel interactions appear in cancer lines. We found that in HMEC, the breast carcinoma amplified sequence gene family (BCAS) 1-4 were among the top 10 most significantly enriched regions of interaction with IGFBP3. 3D-FISH analysis indicated that the translocation-prone BCAS genes, which are located on chromosomes 1, 17, and 20, are in close physical proximity with IGFBP3 and each other in normal breast cells. We also found that epidermal growth factor receptor (EGFR), a gene implicated in tumorigenesis, interacts significantly with IGFBP3 and that this interaction may play a role in their regulation. Breakpoint analysis suggests that when an IGFBP3 interacting region undergoes a translocation an additional interaction detectable by 4C is gained. Overall, our data from multiple lines of evidence suggest an important role for long-range chromosomal interactions in the pathogenesis of cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Pluripotency exit is guided by the Peln1-mediated disruption of intrachromosomal architecture

Yichen Wang, Lin Jia, Cong Wang, Zhonghua Du, Shilin Zhang, Lei Zhou, Xue Wen, Hui Li, Huiling Chen, Yuanyuan Nie, Dan Li, Shanshan Liu, Daniela Salgado Figueroa, Ferhat Ay, Wei Xu, Songling Zhang, Wei Li, Jiuwei Cui, Andrew R. Hoffman, Hui Guo, Ji-Fan Hu

Summary: Wang et al. identify Peln1 as a key chromatin long non-coding RNA that controls pluripotency exit and intrachromosomal looping in stem cells. Peln1 interacts with the Oct4 promoter, recruits DNMT3A, and alters the epigenotype to disrupt the intrachromosomal loop, leading to pluripotency exit. Peln1 also targets multiple pathway genes associated with stem cell self-renewal.

JOURNAL OF CELL BIOLOGY (2022)

Article Endocrinology & Metabolism

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

Margaret C. S. Boguszewski, Cesar L. Boguszewski, Wassim Chemaitilly, Laurie E. Cohen, Judith Gebauer, Claire Higham, Andrew R. Hoffman, Michel Polak, Kevin C. J. Yuen, Nathalie Alos, Zoltan Antal, Martin Bidlingmaier, Beverley M. K. Biller, George Brabant, Catherine S. Y. Choong, Stefano Cianfarani, Peter E. Clayton, Regis Coutant, Adriane A. Cardoso-Demartini, Alberto Fernandez, Adda Grimberg, Kolbeinn Gudmundsson, Jaime Guevara-Aguirre, Ken K. Y. Ho, Reiko Horikawa, Andrea M. Isidori, Jens Otto Lunde Jorgensen, Peter Kamenicky, Niki Karavitaki, John J. Kopchick, Maya Lodish, Xiaoping Luo, Ann McCormack, Lillian Meacham, Shlomo Melmed, Sogol Mostoufi Moab, Hermann L. Muller, Sebastian J. C. M. M. Neggers, Manoel H. Aguiar Oliveira, Keiichi Ozono, Patricia A. Pennisi, Vera Popovic, Sally Radovick, Lars Savendahl, Philippe Touraine, Hanneke M. van Santen, Gudmundur Johannsson

Summary: Growth hormone replacement therapy is not associated with primary tumor or cancer recurrence. The risk of secondary neoplasia from GH replacement is minimal compared to other factors. GH replacement may be considered in adult cancer survivors in remission after careful risk/benefit analysis.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

Association Between Muscle Mass Determined by D3-Creatine Dilution and Incident Fractures in a Prospective Cohort Study of Older Men

Peggy M. Cawthon, Katherine E. Peters, Steven R. Cummings, Eric S. Orwoll, Andrew R. Hoffman, Kristine E. Ensrud, Jane A. Cauley, William J. Evans

Summary: The study investigates the relationship between total skeletal muscle mass and incident fractures. The findings indicate that low D3Cr muscle mass is associated with an increased risk of hip and potentially other fractures in older men, and this association is partially mediated by physical performance.

JOURNAL OF BONE AND MINERAL RESEARCH (2022)

Article Multidisciplinary Sciences

Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs

Simon Eschweiler, Ciro Ramirez-Suastegui, Yingcong Li, Emma King, Lindsey Chudley, Jaya Thomas, Oliver Wood, Adrian von Witzleben, Danielle Jeffrey, Katy McCann, Hayley Simon, Monalisa Mondal, Alice Wang, Martina Dicker, Elena Lopez-Guadamillas, Ting-Fang Chou, Nicola A. Dobbs, Louisa Essame, Gary Acton, Fiona Kelly, Gavin Halbert, Joseph J. Sacco, Andrew Graeme Schache, Richard Shaw, James Anthony McCaul, Claire Paterson, Joseph H. Davies, Peter A. Brennan, Rabindra P. Singh, Paul M. Loadman, William Wilson, Allan Hackshaw, Gregory Seumois, Klaus Okkenhaug, Gareth J. Thomas, Terry M. Jones, Ferhat Ay, Greg Friberg, Mitchell Kronenberg, Bart Vanhaesebroeck, Pandurangan Vijayanand, Christian H. Ottensmeier

Summary: This study assessed the effects of PI3K delta inhibitors in patients with head and neck cancer, finding that it reduced the number of regulatory T cells in tumors and enhanced the cytotoxic potential of tumor-infiltrating T cells. However, high doses of the inhibitors led to immune-related adverse events, indicating the need for alternative dosing regimens to limit toxicity.

NATURE (2022)

Article Ophthalmology

Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease

Connie M. Sears, Amee D. Azad, Linus Amarikwa, Brandon H. Pham, Clara J. Men, Daniel N. Kaplan, Jocelyn Liu, Andrew R. Hoffman, Austin Swanson, Jennifer Alyono, Jennifer Y. Lee, Chrysoula Dosiou, Andrea L. Kossler

Summary: This study aims to characterize the frequency, severity, and resolution of hearing dysfunction in patients treated with teprotumumab for TED. The study found that hearing loss is a concerning adverse event of teprotumumab, and further studies are needed to understand its mechanism and reversibility. Baseline audiometry and repeat testing are recommended for monitoring and prevention.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2022)

Review Cell Biology

Eukaryotic translation initiation factor eIF4G2 opens novel paths for protein synthesis in development, apoptosis and cell differentiation

Yudi Liu, Jiuwei Cui, Andrew R. Hoffman, Ji-Fan Hu

Summary: Protein translation is a critical regulatory event involved in various physiological and pathological processes. The eukaryotic translation initiation factor 4G2 (eIF4G2) is important for cap-independent translation initiation via internal ribosome entry sites (IRESs), but recent findings suggest that it plays a role in other translation initiation pathways as well. This review summarizes the role of eIF4G2 in different translation initiation events and its involvement in apoptosis, cell survival, cell differentiation, and embryonic development.

CELL PROLIFERATION (2023)

Article Allergy

Lymphotoxin beta receptor signaling directly controls airway smooth muscle deregulation and asthmatic lung dysfunction

Haruka Miki, William B. Kiosses, Mario C. Manresa, Rinkesh K. Gupta, Gurupreet S. Sethi, Rana Herro, Ricardo Da Silva Antunes, Paramita Dutta, Marina Miller, Kai Fung, Ashu Chawla, Katarzyna Dobaczewska, Ferhat Ay, David H. Broide, Alexei V. Tumanov, Michael Croft

Summary: This study found that signaling through lymphotoxin beta receptor and herpesvirus entry mediator from LIGHT directly controls the dysregulation of airway smooth muscle cells in asthma. By using animal models and in vitro experiments, it was discovered that these receptors play a crucial role in airway smooth muscle hyperresponsiveness and remodeling.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Article Biotechnology & Applied Microbiology

LncRNA Osilr9 coordinates promoter DNA demethylation and the intrachromosomal loop structure required for maintaining stem cell pluripotency

Yanbo Zhu, Zi Yan, Changhao Fu, Xue Wen, Lin Jia, Lei Zhou, Zhonghua Du, Cong Wang, Yichen Wang, Jingcheng Chen, Yuanyuan Nie, Wenjun Wang, Jiuwei Cui, Guixia Wang, Andrew R. Hoffman, Ji-Fan Hu, Wei Li

Summary: By combining CRIST-seq and RNA sequencing, researchers identified a pluripotency-associated lncRNA Osilr9, which plays a critical role in maintaining the pluripotency of stem cells by coordinating the promoter activity of core stem cell factor genes. Osilr9 binds to the Oct4 promoter and recruits a DNA demethylase to induce promoter demethylation, thus facilitating the maintenance of pluripotency.

MOLECULAR THERAPY (2023)

Review Critical Care Medicine

Growth Hormone Deficiency following Traumatic Brain Injury in Pediatric and Adolescent Patients: Presentation, Treatment, and Challenges of Transitioning from Pediatric to Adult Services

Tamara L. Wexler, Kent Reifschneider, Philippe Backeljauw, Javier F. Cardenas, Andrew R. Hoffman, Bradley S. Miller, Kevin C. J. Yuen

Summary: Traumatic brain injury (TBI) is a serious condition that can lead to various consequences, including deficiencies in pituitary hormones. Growth hormone deficiency (GHD) is the most common pituitary hormone deficiency post-TBI and is associated with numerous adverse effects on health outcomes. However, research on post-TBI GHD in pediatric and adolescent patients is limited, and diagnostic and treatment recommendations are lacking. This review addresses the occurrence and diagnosis of TBI, analyzes the prevalence rates of post-TBI hypopituitarism and GHD in pediatric and adolescent patients, and discusses appropriate testing strategies and dosage recommendations for GH treatment.

JOURNAL OF NEUROTRAUMA (2023)

Article Multidisciplinary Sciences

3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma

Konstantin Okonechnikov, Aylin Camgoez, Owen Chapman, Sameena Wani, Donglim Esther Park, Jens-Martin Huebner, Abhijit Chakraborty, Meghana Pagadala, Rosalind Bump, Sahaana Chandran, Katerina Kraft, Rocio Acuna-Hidalgo, Derek Reid, Kristin Sikkink, Monika Mauermann, Edwin F. Juarez, Anne Jenseit, James T. Robinson, Kristian W. Pajtler, Till Milde, Natalie Jaeger, Petra Fiesel, Ling Morgan, Sunita Sridhar, Nicole G. Coufal, Michael Levy, Denise Malicki, Charlotte Hobbs, Stephen Kingsmore, Shareef Nahas, Matija Snuderl, John Crawford, Robert J. Wechsler-Reya, Tom Belle Davidson, Jennifer Cotter, George Michaiel, Gudrun Fleischhack, Stefan Mundlos, Anthony Schmitt, Hannah Carter, Kulandaimanuvel Antony Michealraj, Sachin A. Kumar, Michael D. Taylor, Jeremy Rich, Frank Buchholz, Jill P. Mesirov, Stefan M. Pfister, Ferhat Ay, Jesse R. Dixon, Marcel Kool, Lukas Chavez

Summary: This study investigates the chromosomal conformations and regulatory mechanisms associated with aberrant gene expression in ependymoma tumors. The researchers identified new topologically associating domains, group-specific chromatin loops, and the replacement of CTCF insulators by DNA hyper-methylation. Inhibition experiments confirmed that genes implicated by these 3D genome conformations are essential for the survival of patient-derived ependymoma models.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

Profiling mitochondria-polyribosome lncRNAs associated with pluripotency

Lei Zhou, Hui Li, Tingge Sun, Xue Wen, Chao Niu, Min Li, Wei Li, Miguel A. Esteban, Andrew R. Hoffman, Ji-Fan Hu, Jiuwei Cui

Summary: This study investigates the factors regulating inter-organelle crosstalk in pluripotent stem cells through the analysis of long non-coding RNAs and identifies non-coding RNAs related to stem cell reprogramming and exit from pluripotency. This research provides a valuable resource for understanding the molecular mechanisms underlying pluripotency.

SCIENTIFIC DATA (2023)

Meeting Abstract Urology & Nephrology

CAN MUSCLE MASS EXPLAIN THE RELATIONSHIP BETWEEN EGFRDIFF (=EGFRCYSEGFRCR) AND FRAILTY IN OLDER MEN?

Julia H. Yuan, Dena E. Rifkin, Charles Ginsberg, Peggy Cawthon, Deborah M. Kado, Scott R. Bauer, Kristine Ensrud, Andrew Hoffman, O. Alison Potok

AMERICAN JOURNAL OF KIDNEY DISEASES (2023)

Meeting Abstract Endocrinology & Metabolism

Development of a minimum data set for the monitoring of recombinant human growth hormone (rhGH) therapy in children with growth hormone deficiency (GHD)- a globe-reg initiative

Suet Ching Chen, Evangelia Charmandari, Jin-Ho Choi, Xinyu Dou, Chunxiu Gong, Rasha Hamza, Jamie Harvey, Andrew R. Hoffman, Reiko Horikawa, Gudmundur Johannson, Alexander Jorje, Bradley Miller, Lars Savendahl, Xanthippi Tseretopoulou, Diana Vitali, S. Faisal Ahmed

HORMONE RESEARCH IN PAEDIATRICS (2023)

Meeting Abstract Endocrinology & Metabolism

Development of A Minimum Data Set for A Growth Hormone Module For Pediatric Growth Hormone Deficiency In The Global Registry For Novel Therapies In Rare Bone & Endocrine Conditions - The GloBE-Reg GH Study

Bradley S. Miller, Suet Ching Chen, Evangelia Charmandari, Jin Ho Choi, Xinyu Dou, Chunxiu Gong, Rasha Hamza, Jamie Harvey, Andrew R. Hoffman, Reiko Horikawa, Gudmundur Johannsson, Alexander Jorge, Ryan S. Miller, Sebastian Roehrich, Lars Savendahl, Xanthippi Tseretopoulou, Diana Vitali, Michael P. Wajnrajch, S. Faisal Ahmed

HORMONE RESEARCH IN PAEDIATRICS (2023)

Meeting Abstract Immunology

Therapeutic targeting of tumor necrosis factor like weak inducer of apoptosis (TWEAK) in psoriasis

Rinkesh Kumar Gupta, Donald Gracias, Daniela Salgado Figueroa, Haruka Miki, Jacqueline Miller, Kai Fung, Ferhat Ay, Linda C. Burkly, Michael Croft

JOURNAL OF IMMUNOLOGY (2022)

暂无数据